Cargando…

Efficacy and safety of pemafibrate administration in patients with dyslipidemia: a systematic review and meta-analysis

BACKGROUND: Using a meta-analysis of randomized controlled trials (RCTs), this study aimed to investigate the efficacy and safety of pemafibrate, a novel selective peroxisome proliferator-activated receptor α modulator, in patients with dyslipidemia. METHODS: A search was performed using the MEDLINE...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ida, Satoshi, Kaneko, Ryutaro, Murata, Kazuya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6429757/ https://www.ncbi.nlm.nih.gov/pubmed/30898163 http://dx.doi.org/10.1186/s12933-019-0845-x

Ejemplares similares

Relationship between frailty and mortality, hospitalization, and cardiovascular diseases in diabetes: a systematic review and meta-analysis
por: Ida, Satoshi, et al.
Publicado: (2019)

Effects of oral antidiabetic drugs on left ventricular mass in patients with type 2 diabetes mellitus: a network meta-analysis
por: Ida, Satoshi, et al.
Publicado: (2018)

FRI096 Efficacy Of Pemafibrate In Patients With Dyslipidemia: A Systematic Review And Meta - Analysis Of Randomized Controlled Trials
por: Caroline Cristine, Almeida Balieiro, et al.
Publicado: (2023)

Association between Sarcopenia and Renal Function in Patients with Diabetes: A Systematic Review and Meta-Analysis
por: Ida, Satoshi, et al.
Publicado: (2019)

Utility of Real-Time and Retrospective Continuous Glucose Monitoring in Patients with Type 2 Diabetes Mellitus: A Meta-Analysis of Randomized Controlled Trials
por: Ida, Satoshi, et al.
Publicado: (2019)

Effects of pioglitazone treatment on blood leptin levels in patients with type 2 diabetes
por: Ida, Satoshi, et al.
Publicado: (2017)

Effect of trelagliptin on vascular endothelial functions and serum adiponectin level in patients with type 2 diabetes: a preliminary single-arm prospective pilot study
por: Ida, Satoshi, et al.
Publicado: (2016)

Clinical Applications of a Novel Selective PPARα Modulator, Pemafibrate, in Dyslipidemia and Metabolic Diseases
por: Yamashita, Shizuya, et al.
Publicado: (2019)

Efficacy and safety of pemafibrate in patients with chronic kidney disease: A retrospective study
por: Iwasaki, Masako, et al.
Publicado: (2023)

Novel Selective PPARα Modulator Pemafibrate for Dyslipidemia, Nonalcoholic Fatty Liver Disease (NAFLD), and Atherosclerosis †
por: Yamashita, Shizuya, et al.
Publicado: (2023)

Efficacy and safety of saroglitazar for the management of dyslipidemia: A systematic review and meta-analysis of interventional studies
por: Chhabra, Manik, et al.
Publicado: (2022)

Efficacy and Safety of Low-Dose Pemafibrate Therapy for Hypertriglyceridemia in Patients with Type 2 Diabetes
por: Bando, Hidenori, et al.
Publicado: (2021)

Efficacy and Safety of Pemafibrate Versus Bezafibrate to Treat Patients with Hypertriglyceridemia: A Randomized Crossover Study
por: Nakamura, Akihiro, et al.
Publicado: (2023)

Efficacy and Safety of Pemafibrate Versus Bezafibrate to Treat Patients with Hypertriglyceridemia: A Randomized Crossover Study
por: Nakamura, Akihiro, et al.
Publicado: (2023)

The efficacy and safety of co-administration of fimasartan and rosuvastatin to patients with hypertension and dyslipidemia
por: Rhee, Moo-Yong, et al.
Publicado: (2017)

Efficacy and safety of flurbiprofen axetil in the prevention of pain on propofol injection: A systematic review and meta-analysis
por: Zhang, Lieliang, et al.
Publicado: (2014)

Efficacy and safety of bempedoic acid for prevention of cardiovascular events and diabetes: a systematic review and meta-analysis
por: Wang, Xing, et al.
Publicado: (2020)

Pemafibrate, a New Selective PPARα Modulator: Drug Concept and Its Clinical Applications for Dyslipidemia and Metabolic Diseases
por: Yamashita, Shizuya, et al.
Publicado: (2020)

Marked effects of novel selective peroxisome proliferator-activated receptor α modulator, pemafibrate in severe hypertriglyceridemia: preliminary report
por: Iitake, Chie, et al.
Publicado: (2020)

Meta-analysis of the Efficacy and Safety of Adjunctive Rosuvastatin for Dyslipidemia in Patients with Schizophrenia
por: UNGVARI, Gabor S., et al.
Publicado: (2018)

Efficacy and safety of low‐dose sacubitril/valsartan in heart failure patients: A systematic review and meta‐analysis
por: Chen, Wen‐Wen, et al.
Publicado: (2023)

Safety and efficacy of long-term combination therapy with bezafibrate and ezetimibe in patients with dyslipidemia in the prospective, observational J-COMPATIBLE study
por: Teramoto, Tamio, et al.
Publicado: (2013)

Evaluation of Comparative Efficacy and Safety of Surgical Approaches for Total Hip Arthroplasty: A Systematic Review and Network Meta-analysis
por: Yan, Lei, et al.
Publicado: (2023)

Risk of Infection Associated With Administration of Intravenous Iron: A Systematic Review and Meta-analysis
por: Shah, Akshay A., et al.
Publicado: (2021)

Effects of body composition and liver function after long-term pemafibrate treatment on dyslipidemia-associated non-alcoholic fatty liver disease
por: Ishikawa, Toru, et al.
Publicado: (2023)

Efficacy and safety of rosuvastatin in the management of dyslipidemia
por: Rubba, Paolo, et al.
Publicado: (2009)

Determinants of Dyslipidemia in Africa: A Systematic Review and Meta-Analysis
por: Obsa, Mohammed S., et al.
Publicado: (2022)

Dyslipidemia in Muscular Dystrophy: A Systematic Review and Meta-Analysis
por: Sun, Zeren, et al.
Publicado: (2023)

Combination therapy with pemafibrate (K-877) and pitavastatin improves vascular endothelial dysfunction in dahl/salt-sensitive rats fed a high-salt and high-fat diet
por: Yoshida, Masatoki, et al.
Publicado: (2020)

Pemafibrate Prevents Rupture of Angiotensin II-Induced Abdominal Aortic Aneurysms
por: Amioka, Naofumi, et al.
Publicado: (2022)

Efficacy and safety of pemafibrate in people with type 2 diabetes and elevated triglyceride levels: 52‐week data from the PROVIDE study
por: Araki, Eiichi, et al.
Publicado: (2019)

Safety and efficacy of perioperative benzodiazepine administration: study protocol for a systematic review and meta-analysis
por: Spence, Jessica, et al.
Publicado: (2019)

Efficacy of acute care pathways for older patients: a systematic review and meta-analysis
por: Ijadi Maghsoodi, Abtin, et al.
Publicado: (2022)

Design and rationale of the ODYSSEY DM-DYSLIPIDEMIA trial: lipid-lowering efficacy and safety of alirocumab in individuals with type 2 diabetes and mixed dyslipidaemia at high cardiovascular risk
por: Müller-Wieland, Dirk, et al.
Publicado: (2017)

Effects of pemafibrate on glucose metabolism markers and liver function tests in patients with hypertriglyceridemia: a pooled analysis of six phase 2 and phase 3 randomized double‐blind placebo‐controlled clinical trials
por: Yokote, Koutaro, et al.
Publicado: (2021)

Association of Tranexamic Acid Administration With Mortality and Thromboembolic Events in Patients With Traumatic Injury: A Systematic Review and Meta-analysis
por: Karl, Vivien, et al.
Publicado: (2022)

Comparison of Amitriptyline and US Food and Drug Administration–Approved Treatments for Fibromyalgia: A Systematic Review and Network Meta-analysis
por: Farag, Hussein M., et al.
Publicado: (2022)

Obesity and dyslipidemia in patients with psoriasis treated at a dermatologic clinic in Manaus
por: Santos, Mônica, et al.
Publicado: (2013)

Efficacy and Safety of Antibiotics for Treatment of Scrub Typhus: A Network Meta-analysis
por: Yang, Jiaru, et al.
Publicado: (2020)

Meta-analytic Techniques to Assess the Association Between N-acetylcysteine and Acute Kidney Injury After Contrast Administration: A Systematic Review and Meta-analysis
por: Magner, Kate, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_mv7tav4jqgf46d3gke7cr5r7i0